全文获取类型
收费全文 | 44506篇 |
免费 | 3242篇 |
国内免费 | 269篇 |
专业分类
耳鼻咽喉 | 562篇 |
儿科学 | 883篇 |
妇产科学 | 1095篇 |
基础医学 | 6339篇 |
口腔科学 | 1266篇 |
临床医学 | 4354篇 |
内科学 | 8243篇 |
皮肤病学 | 976篇 |
神经病学 | 3691篇 |
特种医学 | 2372篇 |
外科学 | 6599篇 |
综合类 | 731篇 |
一般理论 | 27篇 |
预防医学 | 3080篇 |
眼科学 | 884篇 |
药学 | 3441篇 |
2篇 | |
中国医学 | 285篇 |
肿瘤学 | 3187篇 |
出版年
2023年 | 233篇 |
2022年 | 517篇 |
2021年 | 961篇 |
2020年 | 577篇 |
2019年 | 949篇 |
2018年 | 1059篇 |
2017年 | 846篇 |
2016年 | 930篇 |
2015年 | 1288篇 |
2014年 | 1643篇 |
2013年 | 2022篇 |
2012年 | 2944篇 |
2011年 | 2908篇 |
2010年 | 1781篇 |
2009年 | 1625篇 |
2008年 | 2320篇 |
2007年 | 2274篇 |
2006年 | 2125篇 |
2005年 | 2064篇 |
2004年 | 1921篇 |
2003年 | 1740篇 |
2002年 | 1585篇 |
2001年 | 1379篇 |
2000年 | 1420篇 |
1999年 | 1156篇 |
1998年 | 438篇 |
1997年 | 386篇 |
1996年 | 395篇 |
1995年 | 322篇 |
1994年 | 268篇 |
1993年 | 248篇 |
1992年 | 675篇 |
1991年 | 586篇 |
1990年 | 578篇 |
1989年 | 531篇 |
1988年 | 457篇 |
1987年 | 432篇 |
1986年 | 387篇 |
1985年 | 368篇 |
1984年 | 356篇 |
1983年 | 279篇 |
1982年 | 181篇 |
1980年 | 170篇 |
1979年 | 252篇 |
1978年 | 190篇 |
1976年 | 159篇 |
1975年 | 173篇 |
1974年 | 180篇 |
1973年 | 178篇 |
1972年 | 192篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
A new range of stand magnifiers has been released by the COIL company in the United Kingdom. Examination of these magnifiers reveals that they fail to deliver the rated magnifications labelled prominently on the appliances, as a result of the manufacturer's conformance with the requirements of the German DIN standard and the use of back vertex power (F'v) rather than equivalent dioptric power (Fm) of the magnifier. In this study we provide information on the optometric parameters of these new stand magnifiers that will assist the more accurate specification of improvements in vision expected from their use. 相似文献
22.
Probable gas embolism during operative hysteroscopy caused by products of combustion 总被引:8,自引:0,他引:8
Ngozi Imasogie Ron Crago Nicholas A. Leyland Frances Chung 《Journal canadien d'anesthésie》2002,49(10):1044-1047
PURPOSE: Gas embolism is a rare but well documented entity during operative hysteroscopy, with an incidence of 10-50%. Catastrophic outcomes occur at a rate of three in 17,000 procedures. The purpose of this report is to present a non-fatal case of gas embolism probably caused by the gaseous products of combustion. CLINICAL FEATURES: A 50-yr-old woman with a history of menorrhagia was scheduled for hysteroscopy and endometrial ablation and polypectomy. Fifteen minutes into the procedure, with the patient in lithotomy position, 20 degree head down tilt, and breathing spontaneously, a sudden oxygen desaturation occurred from 97% to 87%. The patient's end-tidal carbon dioxide dropped from 46 mmHg to 27 mmHg. The patient's breathing pattern remained normal, respiratory rate remained 11-12 breaths x min(-1) but amplitude of the reservoir bag movement was increased. Cardiovascular variables remained stable. She responded rapidly to 100% oxygen and made an uneventful recovery. Having ruled out other possible causes, we concluded gas embolism was responsible for the fall in oxygen saturation and end-tidal CO(2). CONCLUSION: With all the precautions in place to minimize the likelihood of fluid overload and ambient air embolism occurring, we surmised that products of combustion were the cause of the gas embolism. During endometrial ablation, gaseous products of combustion, mainly carbon dioxide, accumulate. The gases may then contribute to the rise in uterine pressure that occurs as irrigation fluid enters the uterus and this rise in pressure in turn encourages passage of gas into the open venous sinuses. 相似文献
23.
P Brennan D Johnson S Rider N Cone M Goldman A Buckpitt H Chung 《Biopharmaceutics & drug disposition》1991,12(7):547-556
The dermal absorption of niclosamide, a drug shown to prevent Schistosomiasis by blocking the dermal penetration of cercariae, has been examined in Sinclair minipigs and rats. Radioactivity in the urine and feces collected daily for 7 days after application of 14C-niclosamide accounted for less than 2 per cent and 10 per cent of the labelled compound applied to pig and rat skin, respectively. Approximately 20 per cent of the radioactivity from the dose solution was recovered on the skin excised from the area of application in both minipigs and rats. No radioactivity was detected in organs removed from the pig 7 days after application of radiolabelled drug while less than 6 per cent of the dose could be accounted for in the rat organs/carcass. Radioactivity in swine blood, removed 0.5, 1, 2, 4 and at 24 h intervals after dosing, was at or below three times background in all of the samples. Total recovery of the applied radioactivity was 78 per cent in pigs and 57 per cent in rats. These studies indicate that niclosamide is very poorly absorbed after dermal application. The results are consistent with earlier comparative studies showing that dermal penetration of xenobiotics in rats is generally higher than in swine. 相似文献
24.
With the increased use of indwelling central venous catheters, increasing numbers of cases of Rhodotorula fungemia have been observed in patients with neoplasia and neutropenia. In most patients with catheter-related Rhodotorula fungemia, the condition has been treated with broadspectrum antibiotics. We report two cases of central venous catheter-related
Rhodotorula rubra fungemia that occurred in patients with acute myeloblastic leukemia. Both patients were in a state of neutropenia. One patient
was treated with amphotericin B and his central venous catheter was removed, but he died of Klebsiella pneumoniae bacteremia. The other patient was treated with amphotericin B and discharged, with a central venous catheter, after recovery
from neutropenia. Although the management of catheter-related Rhodotorula fungemia infections remains controversial, resolution of the underlying disease is more important than catheter removal for
recovery from Rhodotorula rubra fungemia.
Received: August 22, 2001 / Accepted: October 8, 2001 相似文献
25.
26.
A general overview of the literature concerning the development of diabetic neuropathic arthropathy is discussed. A case report is presented dealing with spontaneous fractures of the lesser metatarsal in a patient with an amputated hallux and peripheral neuropathy secondary to diabetes mellitus. 相似文献
27.
28.
K J Meador J L Thompson D W Loring A M Murro D W King B B Gallagher G P Lee J R Smith H F Flanigin 《Neurology》1991,41(6):869-872
Although there has been extensive examination of the behavioral and physiologic correlates of hippocampal theta activity in animals, the human literature consists of a single case study. We investigated the differential effects of four behavioral states on human hippocampal theta activity in 16 epilepsy surgery patients. Behavioral conditions included resting eyes closed (RC), resting eyes open (RO), eyes open with auditory word activation (AW), and eyes open with visuospatial activation (VS). Hippocampal theta activity decreased during both RO and VS compared to both RC and AW. There were reciprocal changes in delta activity. Comparisons of RO to VS and of RC to AW were nonsignificant. The results demonstrate state-specific changes in human hippocampal theta and are consistent with the animal literature that relates hippocampal theta to sensorimotor integration and forebrain volitional mechanisms. 相似文献
29.
Leslee J. Shaw Romalisa Miranda-Peats Piotr Slomka John Friedman Sean W. Hayes Daniel S. Berman Gary V. Heller Marcin Dada William E. Boden Paul Casperson Robert A. O’Rourke Ronald Schwartz William S. Weintraub David J. Maron Spencer King Koon Teo Pamela Hartigan 《Journal of nuclear cardiology》2006,13(5):685-698
Background Stress gated myocardial perfusion single photon emission computed tomography (gSPECT) is increasingly used before and after
intercurrent therapeutic intervention and is the basis for ongoing evaluation in the Department of Veterans Affairs clinical
outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial.
Methods and Results The COURAGE trial is a North American multicenter randomized clinical trial that enrolled 2287 patients to aggressive medical
therapy vs percutaneous coronary intervention plus aggressive medical therapy. Three COURAGE nuclear substudies have been
designed. The goals of substudy 0 are to examine the diagnostic accuracy of the extent and severity of inducible ischemia
at baseline in COURAGE patients compared with patient symptoms and quantitative coronary angiography and to explore the relationship
between inducible ischemia and the benefit from revascularization when added to medical therapy. Substudy 1 will correlate
the extent and severity of provocative ischemia with the frequency, quality, and instability of recurrent symptoms in postcatheterization
patients. Substudy 2 (n _ 300) will examine the usefulness of sequential gSPECT monitoring 6 to 18 months after therapeutic
intervention. Together, these nuclear substudies will evaluate the role of gSPECT to determine the effectiveness of aggressive
risk-factor modifications, lifestyle interventions, and anti-ischemic medical therapies with or without revascularization
in reducing patients’ ischemic burdens.
Conclusions The unfolding of evidence on the application of gSPECT in trials such as COURAGE defines a new era for nuclear cardiology.
We hope the evidence that emerges from the COURAGE trial will further establish the role of nuclear imaging in the evidence-based
management of patients with stable coronary disease.
The COURAGE trial was supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research
and Development in collaboration with the Canadian Institutes of Health Research. Unrestricted research grants were obtained
from Merck & Co; Pfizer Pharmaceuticals; Bristol-Myers Squibb Medical Imaging; Astellas Pharma; Kos Pharmaceuticals; Data
Scope; Astra Zeneca Pharmaceuticals; Astra-Zeneca-Canada; Schering-Plough Coorporation, Ltd; Sanofi-Aventis, Inc; First Horizon;
and GE Healthcare. All industrial funding for this trial was directed through the Department of Veterans Affairs. Additional
funding for this substudy was provided by grants to the Department of Veterans Affairs and Canadian Institutes of Health Research
from Astellas Pharma and Bristol-Myers-Squibb Medical Imaging. 相似文献
30.